Quantification of Postdiagnosis Cancer Patient Navigation

Patient navigation is a key component in achieving optimal cancer care outcomes. While a vast amount of literature suggests its clear benefits in cancer care, limited objective data exists regarding navigation metrics, specifically the number of navigator-patient contacts and time spent with patient...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:American journal of clinical oncology Ročník 48; číslo 12; s. 610
Hlavní autoři: Posani, Sarojini, Burnette, Ursula J, McClelland, 3rd, Shearwood
Médium: Journal Article
Jazyk:angličtina
Vydáno: United States 01.12.2025
Témata:
ISSN:1537-453X, 1537-453X
On-line přístup:Zjistit podrobnosti o přístupu
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract Patient navigation is a key component in achieving optimal cancer care outcomes. While a vast amount of literature suggests its clear benefits in cancer care, limited objective data exists regarding navigation metrics, specifically the number of navigator-patient contacts and time spent with patients. This study attempts to attain findings from the published literature to better understand navigation metrics to achieve optimal cancer care outcomes. A systematic PubMed search was performed in April 2025 focusing on cancer patient navigation, with the term "patient navigation or navigator in postdiagnosis cancer care-contact metrics." Important metrics analysed were the median number of navigator-patient contacts, the median time spent per patient, the most common barriers addressed, and their respective improved outcomes. These metrics were then compared with results from the ongoing Phase I Navigator-Assisted Hypofractionation (NAVAH) trial (clinicaltrials.gov, NCT05978232). A total of 7 peer-reviewed studies met the inclusion criteria. The number of patient-navigator contacts widely ranged from 1 to 119; the average being 13.4 (∼0.3 times/mo, compared with 2 times/mo in NAVAH). The median time spent per patient varied from 40 minutes to over 10 hours (compared with 20 mins/encounter in NAVAH). The most commonly discussed topic was financial assistance, which is consistent with NAVAH findings. Improved outcomes were significantly reduced treatment interruption days and securing early specialist appointments. As previously published data depicted wide variability, it highlights the need for standardized data collection and reporting practices, as such quantitative data can facilitate the evolution of patient navigation in achieving improved cancer care outcomes.
AbstractList Patient navigation is a key component in achieving optimal cancer care outcomes. While a vast amount of literature suggests its clear benefits in cancer care, limited objective data exists regarding navigation metrics, specifically the number of navigator-patient contacts and time spent with patients. This study attempts to attain findings from the published literature to better understand navigation metrics to achieve optimal cancer care outcomes.OBJECTIVESPatient navigation is a key component in achieving optimal cancer care outcomes. While a vast amount of literature suggests its clear benefits in cancer care, limited objective data exists regarding navigation metrics, specifically the number of navigator-patient contacts and time spent with patients. This study attempts to attain findings from the published literature to better understand navigation metrics to achieve optimal cancer care outcomes.A systematic PubMed search was performed in April 2025 focusing on cancer patient navigation, with the term "patient navigation or navigator in postdiagnosis cancer care-contact metrics." Important metrics analysed were the median number of navigator-patient contacts, the median time spent per patient, the most common barriers addressed, and their respective improved outcomes. These metrics were then compared with results from the ongoing Phase I Navigator-Assisted Hypofractionation (NAVAH) trial (clinicaltrials.gov, NCT05978232).METHODSA systematic PubMed search was performed in April 2025 focusing on cancer patient navigation, with the term "patient navigation or navigator in postdiagnosis cancer care-contact metrics." Important metrics analysed were the median number of navigator-patient contacts, the median time spent per patient, the most common barriers addressed, and their respective improved outcomes. These metrics were then compared with results from the ongoing Phase I Navigator-Assisted Hypofractionation (NAVAH) trial (clinicaltrials.gov, NCT05978232).A total of 7 peer-reviewed studies met the inclusion criteria. The number of patient-navigator contacts widely ranged from 1 to 119; the average being 13.4 (∼0.3 times/mo, compared with 2 times/mo in NAVAH). The median time spent per patient varied from 40 minutes to over 10 hours (compared with 20 mins/encounter in NAVAH). The most commonly discussed topic was financial assistance, which is consistent with NAVAH findings. Improved outcomes were significantly reduced treatment interruption days and securing early specialist appointments.RESULTSA total of 7 peer-reviewed studies met the inclusion criteria. The number of patient-navigator contacts widely ranged from 1 to 119; the average being 13.4 (∼0.3 times/mo, compared with 2 times/mo in NAVAH). The median time spent per patient varied from 40 minutes to over 10 hours (compared with 20 mins/encounter in NAVAH). The most commonly discussed topic was financial assistance, which is consistent with NAVAH findings. Improved outcomes were significantly reduced treatment interruption days and securing early specialist appointments.As previously published data depicted wide variability, it highlights the need for standardized data collection and reporting practices, as such quantitative data can facilitate the evolution of patient navigation in achieving improved cancer care outcomes.CONCLUSIONSAs previously published data depicted wide variability, it highlights the need for standardized data collection and reporting practices, as such quantitative data can facilitate the evolution of patient navigation in achieving improved cancer care outcomes.
Patient navigation is a key component in achieving optimal cancer care outcomes. While a vast amount of literature suggests its clear benefits in cancer care, limited objective data exists regarding navigation metrics, specifically the number of navigator-patient contacts and time spent with patients. This study attempts to attain findings from the published literature to better understand navigation metrics to achieve optimal cancer care outcomes. A systematic PubMed search was performed in April 2025 focusing on cancer patient navigation, with the term "patient navigation or navigator in postdiagnosis cancer care-contact metrics." Important metrics analysed were the median number of navigator-patient contacts, the median time spent per patient, the most common barriers addressed, and their respective improved outcomes. These metrics were then compared with results from the ongoing Phase I Navigator-Assisted Hypofractionation (NAVAH) trial (clinicaltrials.gov, NCT05978232). A total of 7 peer-reviewed studies met the inclusion criteria. The number of patient-navigator contacts widely ranged from 1 to 119; the average being 13.4 (∼0.3 times/mo, compared with 2 times/mo in NAVAH). The median time spent per patient varied from 40 minutes to over 10 hours (compared with 20 mins/encounter in NAVAH). The most commonly discussed topic was financial assistance, which is consistent with NAVAH findings. Improved outcomes were significantly reduced treatment interruption days and securing early specialist appointments. As previously published data depicted wide variability, it highlights the need for standardized data collection and reporting practices, as such quantitative data can facilitate the evolution of patient navigation in achieving improved cancer care outcomes.
Author Burnette, Ursula J
McClelland, 3rd, Shearwood
Posani, Sarojini
Author_xml – sequence: 1
  givenname: Sarojini
  surname: Posani
  fullname: Posani, Sarojini
  organization: Departments of Radiation Oncology
– sequence: 2
  givenname: Ursula J
  surname: Burnette
  fullname: Burnette, Ursula J
  organization: Department of Radiation Oncology, Case Western Reserve University School of Medicine, Cleveland, OH
– sequence: 3
  givenname: Shearwood
  surname: McClelland, 3rd
  fullname: McClelland, 3rd, Shearwood
  organization: Neurological Surgery, University of Oklahoma Stephenson Cancer Center, University of Oklahoma College of Medicine, Oklahoma City, OK
BackLink https://www.ncbi.nlm.nih.gov/pubmed/40525892$$D View this record in MEDLINE/PubMed
BookMark eNpNj91LwzAUxYNM3If-ByJ99KUzN03a5FGKU2G4CQq-lTQfI9Ims2kF_3urTti9D-fA-XE5d44mPniD0CXgJWBR3JSbcomPBghhJ2gGLCtSyrK3yZGfonmM7yPEclycoSnFjDAuyAyJ50H63lmnZO-CT4JNtiH22smdD9HFpJRemS7ZjrHxffIkP93uFz1Hp1Y20VwcdIFeV3cv5UO63tw_lrfrVJGxUQpggHNNgAhssTSacWUFZhR0jQllteAcqKwzXYxrcw1GWVbnPK-pxRklC3T9d3ffhY_BxL5qXVSmaaQ3YYhVRkBwRpn4Qa8O6FC3Rlf7zrWy-6r-3yXf44dY8g
ContentType Journal Article
Copyright Copyright © 2025 Wolters Kluwer Health, Inc. All rights reserved.
Copyright_xml – notice: Copyright © 2025 Wolters Kluwer Health, Inc. All rights reserved.
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1097/COC.0000000000001225
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
EISSN 1537-453X
ExternalDocumentID 40525892
Genre Systematic Review
Journal Article
GroupedDBID ---
.-D
.XZ
.Z2
0R~
23M
4Q1
4Q2
4Q3
5GY
5RE
5VS
6J9
71W
8L-
AAAAV
AAHPQ
AAIQE
AAJCS
AARTV
AASCR
AAYEP
ABASU
ABBUW
ABDIG
ABJNI
ABPXF
ABVCZ
ABXVJ
ABXYN
ABZAD
ABZZY
ACBKD
ACDDN
ACEWG
ACGFO
ACILI
ACLYX
ACWDW
ACWRI
ACXJB
ACXNZ
ADGGA
ADHPY
ADKSD
AE6
AEBDS
AFBFQ
AFDTB
AFEXH
AFNMH
AGINI
AHQNM
AHQVU
AHVBC
AINUH
AJCLO
AJIOK
AJNWD
AJZMW
AKCTQ
ALKUP
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
AMNEI
AOHHW
AOQMC
BQLVK
C45
CGR
CS3
CUY
CVF
DIWNM
E.X
EBS
ECM
EEVPB
EIF
EX3
F2K
F2L
F5P
FCALG
FL-
GNXGY
GQDEL
H0~
HLJTE
HZ~
IH2
IKREB
IN~
IPNFZ
JK3
JK8
K-A
K-F
K8S
KD2
KMI
L-C
N9A
NPM
O9-
OAG
OAH
ODMTH
OHYEH
OL1
OLG
OLV
OLZ
OPUJH
OVD
OVDNE
OWBYB
OWU
OWV
OWW
OWX
OWY
OWZ
OXXIT
P2P
RIG
RLZ
RXW
S4R
S4S
TEORI
TSPGW
V2I
VVN
W3M
WOQ
WOW
X3V
X3W
XXN
XYM
YFH
YOC
ZFV
7X8
TAF
ID FETCH-LOGICAL-c2225-11e188d21290f0aed58cf90541db0245b98814ab3d7d7df6d1ecf5b686b4f0342
IEDL.DBID 7X8
ISSN 1537-453X
IngestDate Thu Oct 02 22:40:42 EDT 2025
Tue Dec 02 01:41:17 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 12
Keywords patient navigation
breast cancer
radiation oncology
quantification
Language English
License Copyright © 2025 Wolters Kluwer Health, Inc. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c2225-11e188d21290f0aed58cf90541db0245b98814ab3d7d7df6d1ecf5b686b4f0342
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 40525892
PQID 3219854594
PQPubID 23479
ParticipantIDs proquest_miscellaneous_3219854594
pubmed_primary_40525892
PublicationCentury 2000
PublicationDate 2025-December
PublicationDateYYYYMMDD 2025-12-01
PublicationDate_xml – month: 12
  year: 2025
  text: 2025-December
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle American journal of clinical oncology
PublicationTitleAlternate Am J Clin Oncol
PublicationYear 2025
SSID ssj0005607
Score 2.4323215
SecondaryResourceType review_article
Snippet Patient navigation is a key component in achieving optimal cancer care outcomes. While a vast amount of literature suggests its clear benefits in cancer care,...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 610
SubjectTerms Humans
Neoplasms - diagnosis
Neoplasms - therapy
Patient Navigation - statistics & numerical data
Title Quantification of Postdiagnosis Cancer Patient Navigation
URI https://www.ncbi.nlm.nih.gov/pubmed/40525892
https://www.proquest.com/docview/3219854594
Volume 48
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1La8MwDBbbOsYuez-6FxnsGhonTmKfxggruzTrYIPcguMH9JK0zdrfPzlO6WkwWAy5BWJJtmRJ_j6AJyEwZIsj46uYKd96aF8IFfsyTJgRNBZE0o5sIs1zVhR82ifc2r6tcrMndhu1aqTNkY8iXFoM3T2nz_OFb1mjbHW1p9DYhUGEoYy16rTYooWjN08dXqrF9o6KzdU5no6y98xBF_YPCcP49yCzczbj4__-5gkc9WGm9-Ls4hR2dH0GB5O-kH4O_GMlXJtQpxmvMZ6l7VWu8W7Wepm1hqU3dbCrXi7WHRZHU1_A1_j1M3vzexYFlDdOyidEE8ZUaBNOJhAalSINx0iNqMrWXSvOGKGiilSKwySKaGniKmFJRY0FCLyEvbqp9TV4TAk8tyojOAtopBnTNDWSy0BKPGhFwRAeN0Ip0Upt6UHUulm15VYsQ7hyki3nDk6jpJZKj_Hw5g9f38JhaAl4u36SOxgYXKP6Hvbl-nvWLh869eM7n05-ADUnuDI
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Quantification+of+Postdiagnosis+Cancer+Patient+Navigation&rft.jtitle=American+journal+of+clinical+oncology&rft.au=Posani%2C+Sarojini&rft.au=Burnette%2C+Ursula+J&rft.au=McClelland%2C+3rd%2C+Shearwood&rft.date=2025-12-01&rft.eissn=1537-453X&rft.volume=48&rft.issue=12&rft.spage=610&rft_id=info:doi/10.1097%2FCOC.0000000000001225&rft_id=info%3Apmid%2F40525892&rft_id=info%3Apmid%2F40525892&rft.externalDocID=40525892
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1537-453X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1537-453X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1537-453X&client=summon